Register information Patent

DE file number : 60 2011 029 375.3 (Status: pending/in force, Query started: May 4, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 029 375.3
96EP file numberEAKZ11 76 8163.5
86WO file numberWAKZPCT/IB2011/054119
97EP publication numberEPN2621493
87WO publication numberWPN2012042433
54Designation/titleTIN1-PYRAZOLOSPIROKETON-ACETYL-COA-CARBOXYLASEHEMMER
51IPC main classICM
(ICMV)		 A61K 31/438 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07D 471/10 (2006.01), C07D 491/20 (2006.01), A61P 3/10 (2006.01)
22DE application dateDATSep 20, 2011
96EP application dateEATSep 20, 2011
86WO application dateWATSep 20, 2011
43Date of first publicationOTApr 5, 2012
Date of publication of grantPETAug 17, 2016
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
72InventorINDIDIUK, Mary Theresa, Madison, Connecticut 06443, US; DOW, Robert Lee, Groton, Connecticut 06340, US; GRIFFITH, David Andrew, Cambridge, Massachusetts 02140, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
388102 P
Sep 30, 2010
Due dateFT
FG		Sep 30, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002621493
Searchable text: EP000002621493
Original document: EP000002621493B1
Searchable text: EP000002621493B1
Original document: WO002012042433
Searchable text: WO002012042433
43Date of first publicationEVTApr 5, 2012
Date of the first transfer into DPMAregisterEREGTSep 20, 2013
Date of the (most recent) update in DPMAregisterREGTAug 21, 2024
(Show all update days)(Hide all update days)
  • Aug 21, 2024
    • Due date: changed
  • Jul 24, 2024
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 05.04.2012: deleted
  • Jan 2, 2024; Dec 22, 2023; Aug 17, 2023; Jul 13, 2023; Jun 3, 2023; Jun 28, 2022; Aug 18, 2021; Aug 18, 2020; Aug 21, 2019; Aug 24, 2018; Oct 14, 2017; Aug 31, 2017; Jul 27, 2017; Nov 17, 2016; Nov 11, 2016; Oct 6, 2016; Aug 26, 2016; Aug 18, 2016
    • Historical data not available for this/these date(s)
  • Sep 20, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Apr 5, 2012  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Aug 7, 2013  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Sep 19, 2013 Sep 19, 2013 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 17, 2016  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Oct 6, 2016 Oct 6, 2016 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 18, 2017 Aug 31, 2017 Details anzeigen
7 New applicant/owner details New applicant/owner details Jun 2, 2023 Jul 13, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTApr 5, 2012
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTAug 7, 2013
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTSep 19, 2013
Issue numberHN38
YearPJ2013
Publication dateVTSep 19, 2013
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 17, 2016
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTOct 6, 2016
Issue numberHN40
YearPJ2016
Publication dateVTOct 6, 2016
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 18, 2017
Issue numberHN35
YearPJ2017
Publication dateVTAug 31, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 2, 2023
Issue numberHN28
YearPJ2023
Publication dateVTJul 13, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
71/73Previous applicant/ownerINHFPfizer Inc., New York, N.Y., US
Date of update of the procedureREGTJul 13, 2023